{
    "meta": {
        "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
        "terms": "https://open.fda.gov/terms/",
        "license": "https://open.fda.gov/license/",
        "last_updated": "2023-04-27",
        "results": {
            "skip": 0,
            "limit": 1,
            "total": 12898
        }
    },
    "results": [
        {
            "safetyreportversion": "3",
            "safetyreportid": "10003860",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20150720",
            "reporttype": "1",
            "serious": "1",
            "seriousnesshospitalization": "1",
            "receivedateformat": "102",
            "receivedate": "20140312",
            "receiptdateformat": "102",
            "receiptdate": "20150331",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-BAYER-2014-035493",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "BAYER",
                "duplicatenumb": "US-BAYER-2014-035493"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "patientonsetage": "25",
                "patientonsetageunit": "801",
                "patientagegroup": "5",
                "patientweight": "49.89",
                "patientsex": "2",
                "reaction": [
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Injury"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "General physical health deterioration"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Cerebrovascular arteriovenous malformation",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Gastrooesophageal reflux disease"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Peripheral artery thrombosis"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Pain"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Anxiety"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Abdominal pain"
                    },
                    {
                        "reactionmeddraversionpt": "18.0",
                        "reactionmeddrapt": "Emotional distress"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMITRIPTYLINE",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MG, ONCE AT NIGHT",
                        "drugindication": "NECK PAIN",
                        "activesubstance": {
                            "activesubstancename": "AMITRIPTYLINE"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "YAZ",
                        "drugauthorizationnumb": "021676",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "FILM-COATED TABLET",
                        "drugstartdateformat": "610",
                        "drugstartdate": "200804",
                        "drugenddateformat": "610",
                        "drugenddate": "200807",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "DROSPIRENONE\\ETHINYL ESTRADIOL"
                        },
                        "openfda": {
                            "application_number": [
                                "NDA021676"
                            ],
                            "brand_name": [
                                "YAZ"
                            ],
                            "generic_name": [
                                "DROSPIRENONE AND ETHINYL ESTRADIOL"
                            ],
                            "manufacturer_name": [
                                "Bayer HealthCare Pharmaceuticals Inc."
                            ],
                            "product_ndc": [
                                "50419-405"
                            ],
                            "product_type": [
                                "HUMAN PRESCRIPTION DRUG"
                            ],
                            "rxcui": [
                                "630734",
                                "748797",
                                "748798",
                                "748856"
                            ],
                            "spl_id": [
                                "bd3baa73-1d24-49e2-9120-fa7c82f3af90"
                            ],
                            "spl_set_id": [
                                "065f33e4-b587-4e66-b896-ca9ab7b7c876"
                            ],
                            "package_ndc": [
                                "50419-405-03"
                            ]
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "REOPRO",
                        "activesubstance": {
                            "activesubstancename": "ABCIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACIPHEX",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "2",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "804",
                        "drugdosagetext": "20 MG, BID",
                        "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE",
                        "activesubstance": {
                            "activesubstancename": "RABEPRAZOLE SODIUM"
                        },
                        "openfda": {
                            "application_number": [
                                "NDA020973"
                            ],
                            "brand_name": [
                                "ACIPHEX"
                            ],
                            "generic_name": [
                                "RABEPRAZOLE SODIUM"
                            ],
                            "manufacturer_name": [
                                "Eisai Inc.",
                                "Woodward Pharma Services LLC"
                            ],
                            "product_ndc": [
                                "62856-243",
                                "69784-243"
                            ],
                            "product_type": [
                                "HUMAN PRESCRIPTION DRUG"
                            ],
                            "route": [
                                "ORAL"
                            ],
                            "substance_name": [
                                "RABEPRAZOLE SODIUM"
                            ],
                            "rxcui": [
                                "854868",
                                "854870"
                            ],
                            "spl_id": [
                                "e00fa711-01d4-48ba-9c3a-594fb6abff02",
                                "be3a78bc-4f9c-473f-bb62-bd1d6920b5ec"
                            ],
                            "spl_set_id": [
                                "5d103551-978f-472a-9c62-51e6e4dea068",
                                "42282e11-3179-420e-b979-e53dd5bd4b12"
                            ],
                            "package_ndc": [
                                "62856-243-30",
                                "62856-243-90",
                                "62856-243-41",
                                "69784-243-30"
                            ],
                            "unii": [
                                "3L36P16U4R"
                            ]
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TOPAMAX",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG,ONCE IN THE MORNING",
                        "drugindication": "SEIZURE",
                        "activesubstance": {
                            "activesubstancename": "TOPIRAMATE"
                        },
                        "openfda": {
                            "application_number": [
                                "NDA020505",
                                "NDA020844"
                            ],
                            "brand_name": [
                                "TOPAMAX"
                            ],
                            "generic_name": [
                                "TOPIRAMATE"
                            ],
                            "manufacturer_name": [
                                "Janssen Pharmaceuticals, Inc."
                            ],
                            "product_ndc": [
                                "50458-639",
                                "50458-640",
                                "50458-641",
                                "50458-642",
                                "50458-647",
                                "50458-645"
                            ],
                            "product_type": [
                                "HUMAN PRESCRIPTION DRUG"
                            ],
                            "route": [
                                "ORAL"
                            ],
                            "substance_name": [
                                "TOPIRAMATE"
                            ],
                            "rxcui": [
                                "151226",
                                "151227",
                                "151228",
                                "151229",
                                "152855",
                                "199888",
                                "199889",
                                "199890",
                                "205315",
                                "205316",
                                "845478",
                                "845479"
                            ],
                            "spl_id": [
                                "fb80f4b4-14e7-484c-e053-6294a90af892"
                            ],
                            "spl_set_id": [
                                "21628112-0c47-11df-95b3-498d55d89593"
                            ],
                            "package_ndc": [
                                "50458-639-65",
                                "50458-640-65",
                                "50458-641-65",
                                "50458-642-65",
                                "50458-647-65",
                                "50458-645-65"
                            ],
                            "nui": [
                                "N0000008486",
                                "N0000185506",
                                "N0000182140"
                            ],
                            "pharm_class_pe": [
                                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                            ],
                            "pharm_class_moa": [
                                "Cytochrome P450 3A4 Inducers [MoA]",
                                "Cytochrome P450 2C19 Inhibitors [MoA]"
                            ],
                            "unii": [
                                "0H73WJJ391"
                            ]
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "YASMIN",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "FILM-COATED TABLET",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2005",
                        "drugenddateformat": "602",
                        "drugenddate": "2005",
                        "activesubstance": {
                            "activesubstancename": "DROSPIRENONE\\ETHINYL ESTRADIOL"
                        },
                        "openfda": {
                            "application_number": [
                                "NDA021098"
                            ],
                            "brand_name": [
                                "YASMIN"
                            ],
                            "generic_name": [
                                "DROSPIRENONE AND ETHINYL ESTRADIOL"
                            ],
                            "manufacturer_name": [
                                "Bayer HealthCare Pharmaceuticals Inc."
                            ],
                            "product_ndc": [
                                "50419-402"
                            ],
                            "product_type": [
                                "HUMAN PRESCRIPTION DRUG"
                            ],
                            "rxcui": [
                                "284207",
                                "748797",
                                "748800",
                                "748857"
                            ],
                            "spl_id": [
                                "0940c8a8-b5cd-4ba6-9fc8-ca4f55ae3973"
                            ],
                            "spl_set_id": [
                                "d7ea6a60-5a56-4f81-b206-9b27b7e58875"
                            ],
                            "package_ndc": [
                                "50419-402-03"
                            ]
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 200807"
                }
            }
        }
    ]
}